Last reviewed · How we verify

NCT07338643

The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer

Not yet recruiting Last updated 14 January 2026
What this trial tests

trial testing AI group in Abdominal Pain in 1,200 participants. Not yet recruiting.

Timeline
26 February 2026
Primary endpoint
1 August 2028
1 August 2028

Quick facts

Lead sponsorLimian Er
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment1,200
Start date26 February 2026
Primary completion1 August 2028
Estimated completion1 August 2028
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Limian Er

Who can join

Eligibility, any sex, with Abdominal Pain or Black Stools. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Abdominal Pain

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07338643.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing